Company Filing History:
Years Active: 1996-1997
Title: Innovations by James P. Ebben in Hemodialysis Technology
Introduction
James P. Ebben is a notable inventor based in Hudson, WI (US), recognized for his contributions to medical technology, particularly in the field of hemodialysis. With a total of 2 patents, his work focuses on improving patient care through innovative monitoring systems.
Latest Patents
One of his latest patents is a hemodialysis monitoring system designed for hemodialysis machines. This advanced system provides real-time monitoring of hemodialysis treatment, quantifying the rate and amount of constituents, such as urea, removed during the process. By measuring constituent concentrations over time in the spent dialysate effluent, the system enhances the understanding of treatment efficacy. It periodically removes a quantity of spent dialysate effluent from the waste line for testing, allowing for the analysis of a urea concentration time profile. This analysis helps determine critical indices such as urea removal, KT/V, URR, SRI, and normalized protein catabolic rate (nPCR). The system is designed to obtain a dialysate sample that is equilibrated with the blood before the start of treatment, and it incorporates a two-pool analysis to account for concentration differences in the extracellular and intracellular spaces of the patient.
Career Highlights
James P. Ebben has made significant strides in the medical technology sector, particularly through his work at Baxter International Inc. His innovative approaches have contributed to advancements in patient monitoring and treatment efficiency in hemodialysis.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues such as Prakash R. Keshaviah and Paul F. Emerson, further enhancing the impact of his inventions in the medical field.
Conclusion
James P. Ebben's contributions to hemodialysis technology exemplify the importance of innovation in improving patient care. His patents reflect a commitment to advancing medical practices and enhancing treatment outcomes for patients undergoing hemodialysis.